Home
Learn More
Features & Pricing
Success Stories
Contact Us
Search Archives
PRWeb Direct
Submit Release
July 24, 2008
 
Industry Categories  
News by Country  
News by MSA  
Todays News  
Browse by Day  
PR Trackbacks™  
Featured Videos  
ViewNews™  
eBook Digests  
RSS  
PRWeb, a leader in online news and press release distribution, has been used by more than 40,000 organizations of all sizes to increase the visibility of their news, improve their search engine rankings and drive traffic to their Web site.
 
Close Move
All Press Releases for March 2, 2006 Subscribe to this News Feed     Subscribe to this Podcast Feed  
 

Celebrex Lawsuit Set for Trial in Alabama State Court

Woman’s lawsuit claims Pfizer pain relieving drug caused stroke.

Montgomery, Ala. (PRWEB) March 2, 2006 -- A Celebrex lawsuit has been set for trial on June 6, 2006, for a woman who suffered a stroke at age 53, caused by taking the pain relieving drug, Celebrex. The trial will take place in the Circuit Court of Barbour County in Alabama (Rosie Ware v. Pfizer, Inc, Monsanto Company, G.D. Searle, LLC, et al). It will most likely be the first Celebrex case to be tried in the country.

Rosie Ware took Celebrex (Celecoxib), a pharmaceutical treatment for joint pain associated with osteoarthritis and other pain-related conditions. She suffered a stroke in February 2005, and contends it was due to her use of Celebrex. As a result, Ms. Ware’s physical setback cost her substantial sums of money for medical, hospital and related care.

The pharmaceutical industry and Federal Drug Administration have let the American consumer down by manufacturing and quickly approving prescription drugs that cause more harm than good
The lawsuit accuses Pfizer, Inc., Monsanto Company, Pharmacia, and G.D. Searle LLC (a subsidiary of Pharmacia) of failing to warn the medical, pharmaceutical, and scientific communities, and consumers -- including Ms. Ware -- and understating the potential risks and serious side effects associated with the use of Celebrex.

Attorneys representing Ms. Ware are Jere L. Beasley, Andy D. Birchfield, Paul Sizemore, and Navan Ward, Jr. with the law firm of Beasley, Allen, Crow, Methvin, Portis & Miles, P.C. in Montgomery, Alabama, and Shane Seaborn and Myron Penn with the law firm of Penn & Seaborn in Clayton, Alabama.

“The pharmaceutical industry and Federal Drug Administration have let the American consumer down by manufacturing and quickly approving prescription drugs that cause more harm than good,” Beasley said. “How many people need to be at risk or possibly die by taking drugs like Celebrex and Vioxx before industry standards improve?”

# # #

Post Comment:
Trackback URL: http://www.prweb.com/pingpr.php/SG9yci1IYWxmLVNxdWEtSW5zZS1IYWxmLVplcm8=

Technorati Tags

Bookmark -  Del.icio.us | Digg | Furl It | Spurl | RawSugar | Simpy | Shadows | Blink It | My Web


OPTIONS
Printer Friendly Version
Download PDF Version
Download Reader Version
BlogThis
ShareIt

Share The News

Submit this press release easily to any of these major bookmarking and social media sites.

CONTACT INFORMATION
Scott Thomas
BEASLEY ALLEN
800-898-2034
Email us Here
ATTACHED FILES

www.cox2-legal.com/celebrex/

ABOUT PRESS RELEASES
If you have any questions regarding information in these press releases please contact the company listed in the press release. Please do not contact PRWeb. We will be unable to assist you with your inquiry. PRWeb disclaims any content contained in these releases. Our complete disclaimer appears here.
 
Disclaimer: If you have any questions regarding information in these press releases please contact the company listed in the press release.
Please do not contact PRWeb®. We will be unable to assist you with your inquiry.
PRWeb® disclaims any content contained in these releases. Our complete disclaimer appears here.

© Copyright 1997-2008, Vocus PRW Holdings, LLC.
Vocus, PRWeb and Publicity Wire are trademarks or registered trademarks of Vocus, Inc. or Vocus PRW Holdings, LLC.

Terms of Service | Privacy Policy | Copyright